Tubulis is expanding! We are excited to announce the establishment of our US subsidiary, Tubulis Inc., located at the renown CIC (Cambridge Innovation Center) right in the heart of the vibrant Boston biotech hub. We also want to extend a warm welcome to our two new US colleagues, Moetaz Albizem, Senior VP and Head of Clinical Operations, and Yariv Houvras, MD PhD, VP Clinical and Translational Development. With their combined expertise in clinical drug development and medical affairs, particularly for antibody therapeutics, they will greatly contribute to advance the global clinical evaluation of our lead ADC candidate, TUB-040, and support the transition of our preclinical candidates towards clinical phase.

Learn more about our expert team and our pipeline of uniquely matched ADCs targeting www.tubulis.com